Qube Research & Technologies Ltd - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 32 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q3 2023$14,7673,0260.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
EMC Capital Management 123,915$5270.47%
SABBY MANAGEMENT, LLC 34,500$146,6250.13%
XTX Topco Ltd 58,475$248,5190.05%
TANG CAPITAL MANAGEMENT LLC 24,125$102,5310.02%
Tower Research Capital LLC (TRC) 10,037$430.00%
TWO SIGMA INVESTMENTS, LP 47,035$199,8990.00%
Cubist Systematic Strategies, LLC 38,600$164,0500.00%
Renaissance Technologies 20,300$860.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 9,299$39,5210.00%
SIMPLEX TRADING, LLC 10,303$430.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders